GMDA On Track, GNFT Soars, HTBX Sparkles, LLY’s Neutralizing Antibody Therapies Get FDA Nod

(RTTNews) – Today’s Daily Dose brings you news about KalVista’s hereditary angioedema trial results, Heat Biologics’ encouraging data from its phase II trial of HS-110 in non-small cell lung cancer, Gamida’s presentation of full efficacy and safety results of Omidubicel in patienRead MoreMarketsMarkets Feed